4//SEC Filing
Corvus Pharmaceuticals, Inc. 4
Accession 0001104659-16-107413
$CRVSCIK 0001626971operating
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:03 PM ET
Size
5.5 KB
Accession
0001104659-16-107413
Insider Transaction Report
Form 4
Verner Erik J.
V.P., Chemistry Research
Transactions
- Award
Stock Option (Right to Buy)
2016-03-22+60,000→ 60,000 totalExercise: $15.00Exp: 2026-03-22→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The underlying shares subject to the option vest and become exercisable as to one-forty-eighth (1/48th) of the shares subject to the option in successive, equal monthly installments measured from March 22, 2016, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Corvus Pharmaceuticals, Inc.
CIK 0001626971
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001626971
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 4:03 PM ET
- Size
- 5.5 KB